Prosecution Insights
Last updated: November 12, 2026
Application No. 18/721,761

Solid Personal Care Product and Method to Obtain Such Product

Non-Final OA §103§112
Filed
Jun 19, 2024
Priority
Dec 21, 2021 — EU 21383174.6 +1 more
Examiner
COHEN, MICHAEL P
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Universitat Internacional De Catalunya Fundació Privada
OA Round
1 (Non-Final)
59%
Grant Probability
Moderate
1-2
OA Rounds
86%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
510 granted / 865 resolved
-1.0% vs TC avg
Strong +27% interview lift
Without
With
+27.3%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
46 currently pending
Career history
917
Total Applications
across all art units

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Election/Restrictions Applicant's election with traverse of Group I, claims 1-17, in the response dated 8/12/2026, is acknowledged. The traversal is on the ground(s) that: 1. The Bartolucci film does not contain alginate 2. The Bartolucci film comprises multiple layers and the instant film is only a single layer; 3. The Bartolucci film comprises a paper layer and is therefore not soluble; 4. The Bartolucci film comprises an outer layer of insoluble varnish or wax. This is not found persuasive for the following reasons: the claimed invention also possesses multiple layers, as set forth in claims and in the instant specification. See page 27: 1-2 of the specification. The instant invention may be in the form of a core-shell arrangement or a sachet, as disclosed in the instant specification (page 44, 24-27). Bartolucci teaches the layers may contain alginate (pg 13: 5; pg 13:10; pg 13: 13; pg 27:13). Regarding the presence of an insoluble paper layer or an outside layer comprising varnish or wax taught by Bartolucci, the instant specification discloses an outer part that is water insoluble (page 7: 14-16), and further describes the presence of an insoluble polymeric film enveloping the instant product (pg 21: 2-3). As best interpreted by the Examiner, the high solubility of the first and second “subproduct” or layers is restricted to those layers, not other elements in the claimed personal care product. The applicant also argues that the product of Bartolucci is not a personal care product. The Examiner disagrees since Bartolucci teaches the presence in the invention of surfactants for personal care functions (page 28:29-34) and specifically states the invention is useful as a shampoo (page 16:6-10) or a body wash (page 3: 25-27). It is noted that the claim language implies a two layer product since claim 1 recites “the second subproduct is being adapted to contain the first subproduct.” As such the claim is interpreted by the Examiner to comprise two separate elements, wherein the first subproduct is contained to some extent within the second subproduct. The requirement is still deemed proper and is therefore made FINAL. Claims 15 and 18 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. Claim Status Claims 13 is cancelled. Claims 1-12 and 14-18 are pending. Claims 15 and 17-18 are withdrawn. Claims 1-12, 14, and 16 are examined on the merits in this prosecution. CLAIM REJECTIONS Indefiniteness Rejection The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claims 1-12, 14, and 16 are rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. Claim 1 is drawn to a personal care product comprising two subproducts, wherein the second subproduct is a water-soluble dried solid film comprising an alginate, at least one thickening agent such as the elected species of psyllium, and at least one humectant. The broadest reasonable interpretation of the term “psyllium” includes the raw husk of the plant, see the Specification, page 10, lines 19-24, which discloses psyllium as a “water soluble gel-forming mucilage (also known as psyllium hydrocolloid or psyllium seed gum) obtained from the seed husk of Plantago genre plants.” However, as disclosed in the specification, “psyllium” cannot be considered a water-soluble compound since the term “hydrocolloid” is considered to mean the material has insoluble elements that form a viscous gel, since a colloidal system is considered to comprise a solid or semi-solid network that traps a liquid phase, and is therefore not a completely soluble element. Claim 16 is drawn to a number of water-insoluble polymers, including nylon and polyurethane. Obviousness Rejection The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. 1) Claims 1-12 and 14 are rejected under 35 U.S.C. 103 as being unpatentable over Braginsky (WO 2009/032325 A1). Braginsky teaches shaped articles for application to skin and which may contain active and inactive substances including pheromones (Abstract). Braginsky teaches the articles are layered and are suitable for “external application, such as cosmetic or medical pads (pg 19: 8-10). Braginsky teaches freeze-drying of the layers (pg 13: 7-10). Braginsky teaches the layers may contain alginates such as the water-soluble sodium alginate and/or alkaline earth alginates such as calcium alginates that are less soluble or insoluble in water (pg 3: 20-21). Braginsky further teaches that each layer can be manipulated to release active agents in a controlled manner (pg 19: 20-22). Braginsky teaches that each of the layers may contain glycerin as a cosmetically effective compound or moisturizer (pg 15: 24-27). Braginsky further teaches that the layers contain at least one “skeletal-forming agent” or hydrocolloid forming agent such as polyvinyl alcohol (pg 13: 30; pg 23: 25). Regarding the claim 1 limitation of the water solubility of the first and second subproducts, Braginsky teaches the less soluble layer is less than 10 g/liter at 20 oC (pg 11: 30-31). However, the claim recites a higher temperature (up to 30 oC), and one of ordinary skill would expect higher solubility at a higher temperature. Additionally, applicant recites the term “about” in claim 1 with regard to solubilities and does not appear to apply limits to the term in the Specification; as such, the term “about” is defined broadly. While Braginsky does not teach an exact value for the solubility of the more soluble layer that comprises sodium alginate and glycerin, the solubility of sodium alginate can be optimized by manipulating pH and molecular weight of the polymer. For claim 2, Braginsky teaches cosmetic applications of the invention. For claim 3, Braginsky teaches cosmetic applications including a moisturizer (pg 20: 10-16). For claims 4 and 5, Braginsky teaches ingredients including a glycerin and urea as moisturizers (pg 25: 18-19). For claims 6 and 7, Braginsky teaches ingredients including a buffer (pg 27: 30) and/or inorganic salts such as calcium chloride (pg 4: 1; pg 10: 19-20). For claim 8, Braginsky teaches mixtures of glycerin and an alginate, as discussed above. For claim 9, Braginsky teaches compositions comprising alginates (pg 3: 20-21); cellulose as a natural hydrocolloid-forming polymer (pg 13: 29); glycerin; urea (pg 25: 18-19); and xanthan gum (pg 13: 27). For claim 11, Braginsky teaches or suggests a solid film comprising alginate, glycerol, and polyvinyl alcohol, as discussed above. Of note is that Braginsky does not teach or suggest a solid film comprising alginate, glycerol, and psyllium. For claim 14, Braginsky teaches compositions comprising cosmetic active substances (pg 13: 19-22). The examiner acknowledges that some picking and choosing was used to arrive at the instantly claimed methods in view of Braginsky. However, the claimed combination of components, including the multiple layered construct, the layer comprising alginate and glycerol, and the layer comprising alginate, glycerol, and polyvinyl alcohol, is taught as known and used for administration of cosmetic ingredients to the skin. It would have therefore been prima facie obvious to a person having ordinary skill in the art to administer the claimed combination of ingredients, including the cosmetic active, through a topical route of administration with a reasonable expectation of success that the treatment would be efficacious, as taught by Braginsky. 2) Claim 16 is rejected under 35 U.S.C. 103 as being unpatentable over Braginsky (cited above), in view of Harichian (US 2009/0155321 A1).. The teachings of Braginsky are discussed above. Braginsky does not teach a product comprising the polymers claimed in claim 16 including a polyhydroxyalkanoate. Harichian teaches the missing element of Braginsky. Harichian teaches cosmetic compositions comprising encapsulated coloring agents (Abstract), wherein alginates may comprise the core and shell (pg 2, [0029]). The composition also includes glycerol as a humectant (pg 3, [0058]). Harichian also teaches the bead coating or shell and may comprise an alginate and polyhydroxyethyl methacrylate (pg 2, [0029]), reading on a polyhydroxyalkanoate. The skilled artisan would have expected success in adding polyhydroxyethyl methacrylate to alginate in a layer of the cosmetic taught by Braginsky since Harichian teaches the combination of polyhydroxyethyl methacrylate and alginate are useful in a matrix surrounding a layer or core comprising a cosmetic active. CONCLUSION Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL P COHEN whose telephone number is (571)270-7402. The examiner can normally be reached on M-Th 8:30-5:30; F 9-4. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana S. Kaup, can be reached on (571) 272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL P COHEN/Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Jun 19, 2024
Application Filed
Oct 14, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788773
ANTIMICROBIAL COMPOSITIONS CONTAINING POLYPHENYLENE CARBOXYMETHYLENE
4y 1m to grant Granted Nov 10, 2026
Patent 12778883
GASTRIC RESIDENCE SYSTEMS FOR ADMINISTRATION OF ACTIVE AGENTS
4y 6m to grant Granted Nov 03, 2026
Patent 12779047
LINKERS FOR IMPROVING THE STABILITY OF BIOCONJUGATES AND THE SELECTIVITY OF PAYLOAD RELEASE
4y 1m to grant Granted Nov 03, 2026
Patent 12778129
INSECT ATTRACTANT AND KILLING SYSTEM
1y 11m to grant Granted Nov 03, 2026
Patent 12766102
LIPOSOMES AND METHODS OF MAKING THE SAME
4y 3m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
59%
Grant Probability
86%
With Interview (+27.3%)
Low
PTA Risk
Based on 865 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month